NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Avation Medical

Avation Medical

Private
Columbus, OhioHealthcare & Life Scienceshttps://avation.com/

Last Round

Series D

Mar 20, 2026

Total Funding Raised

$34.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Avation Medical is a healthcare technology company that develops wearable nerve modulation systems to provide patient-friendly nerve stimulation therapies for chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neuromodulationoveractive bladderOABwearable medical deviceclosed-loop therapynon-invasive treatmentdigital healthurologyurogynecologybioelectronic medicineEMG sensingat-home therapyfemtechmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avation Medical Comps

Public and private peers based on sector, stage, and business model.

Avation Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Avation Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 20, 2026
Series CFeb 1, 2024
Series BFeb 3, 2021

Avation Medical Investors

Notable investors and investment history

Avation Medical investors
InvestorRounds
Arboretum VenturesSeries C, Series B
Avestria VenturesSeries C, Series B
Angelini VenturesSeries C
ShangBay CapitalSeries C
JobsOhio VenturesSeries C
MedtronicSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Vivally System receives FDA clearance for overactive bladder treatment.

  • Mar 20, 2026

    Completed Series D funding round.

Avation Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avation Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avation Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersColumbus, Ohio
Employee Range77
Year Founded2016
Last FundingMar 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.